119 related articles for article (PubMed ID: 8065450)
1. MHC class II function preserved by low-affinity peptide interactions preceding stable binding.
Sadegh-Nasseri S; Stern LJ; Wiley DC; Germain RN
Nature; 1994 Aug; 370(6491):647-50. PubMed ID: 8065450
[TBL] [Abstract][Full Text] [Related]
2. Cooperativity during the formation of peptide/MHC class II complexes.
Anderson MW; Gorski J
Biochemistry; 2005 Apr; 44(15):5617-24. PubMed ID: 15823020
[TBL] [Abstract][Full Text] [Related]
3. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
Thayer WP; Ignatowicz L; Weber DA; Jensen PE
J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
[TBL] [Abstract][Full Text] [Related]
4. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1.
Natarajan SK; Stern LJ; Sadegh-Nasseri S
J Immunol; 1999 Mar; 162(6):3463-70. PubMed ID: 10092802
[TBL] [Abstract][Full Text] [Related]
5. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
Stumptner P; Benaroch P
EMBO J; 1997 Oct; 16(19):5807-18. PubMed ID: 9312039
[TBL] [Abstract][Full Text] [Related]
6. Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.
Ishioka GY; Adorini L; Guery JC; Gaeta FC; LaFond R; Alexander J; Powell MF; Sette A; Grey HM
J Immunol; 1994 May; 152(9):4310-9. PubMed ID: 8157954
[TBL] [Abstract][Full Text] [Related]
7. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.
Roche PA; Cresswell P
Nature; 1990 Jun; 345(6276):615-8. PubMed ID: 2190094
[TBL] [Abstract][Full Text] [Related]
8. Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro.
Frayser M; Sato AK; Xu L; Stern LJ
Protein Expr Purif; 1999 Feb; 15(1):105-14. PubMed ID: 10024477
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of binding capacities between HLA class II molecules and synthetic peptides HA307-319].
Ikeda K; Katagiri M
Hokkaido Igaku Zasshi; 1993 May; 68(3):318-24. PubMed ID: 8319931
[TBL] [Abstract][Full Text] [Related]
10. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
11. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
[TBL] [Abstract][Full Text] [Related]
12. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of a structural homology model for a class II histocompatibility protein, HLA-DR1: comparison to the crystal structure.
Nauss JL; Reid RH; Sadegh-Nasseri S
J Biomol Struct Dyn; 1995 Jun; 12(6):1213-33. PubMed ID: 7669268
[TBL] [Abstract][Full Text] [Related]
14. In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers.
Yang J; Jaramillo A; Shi R; Kwok WW; Mohanakumar T
Hum Immunol; 2004 Jul; 65(7):692-9. PubMed ID: 15301857
[TBL] [Abstract][Full Text] [Related]
15. Peptide binding inhibits aggregation of soluble MHC class II in solution.
Arimilli S; Astafieva I; Mukku PV; Cardoso C; Deshpande S; Nag B
IUBMB Life; 1999 Nov; 48(5):483-91. PubMed ID: 10637763
[TBL] [Abstract][Full Text] [Related]
16. Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.
Xu M; Jackson R; Adams S; Humphreys RE
Arzneimittelforschung; 1999 Sep; 49(9):791-9. PubMed ID: 10514908
[TBL] [Abstract][Full Text] [Related]
17. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.
Roche PA; Cresswell P
J Immunol; 1990 Mar; 144(5):1849-56. PubMed ID: 2307844
[TBL] [Abstract][Full Text] [Related]
18. A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding.
Zarutskie JA; Sato AK; Rushe MM; Chan IC; Lomakin A; Benedek GB; Stern LJ
Biochemistry; 1999 May; 38(18):5878-87. PubMed ID: 10231540
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.
Ferrante A; Gorski J
J Immunol; 2010 Feb; 184(3):1153-8. PubMed ID: 20038641
[TBL] [Abstract][Full Text] [Related]
20. Directed evolution of soluble single-chain human class II MHC molecules.
Esteban O; Zhao H
J Mol Biol; 2004 Jun; 340(1):81-95. PubMed ID: 15184024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]